By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex and High Throughput Genomics have partnered to develop an integrated assay that Luminex will sell to the gene expression research market.

Luminex said today that the new qBead Gene Expression Assay puts HTG's qNPA chemistry technology on the Luminex xMAP multiplexing platform to create a high-throughput assay with a simplified workflow that requires no extractions, cDNA synthesis, or amplifications, Luminex said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.